Description
The marker is associated with changes in interferon B1 synthesis. It is investigated to detect genetic predisposition to systemic juvenile rheumatoid arthritis, insulin-dependent diabetes mellitus, growth arrest in Crohn's disease, cerebral hemorrhages, and hyperandrogenic diseases. OMIM: 147620.
Period of execution
Within 14 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Buccal (cheek) epithelium
- Venous blood